SPEED BioSystems
Private Company
Funding information not available
Overview
SPEED BioSystems operates as a specialized distributor and service provider in the life sciences research tools market, emphasizing speed and reliability. The company's business model centers on providing a broad catalog of high-demand reagents, antibodies, and lab consumables with an efficient logistics operation tailored for the dense biotech research corridor around the Washington D.C./Maryland area. While not a therapeutic developer, it serves as a critical infrastructure partner for research in diagnostics, proteomics, and drug discovery. Its financial position appears to be revenue-generating through product sales and services, operating as a private entity.
Technology Platform
Integrated logistics and supply chain platform for rapid delivery of life science reagents, combined with capabilities for custom antibody and recombinant protein production.
Opportunities
Risk Factors
Competitive Landscape
SPEED BioSystems competes in the vast life science reagents market against giants like Thermo Fisher, Abcam, and Merck, as well as numerous smaller specialists. Its primary competitive differentiation is its promise of ultra-fast local delivery and personalized service, a niche not efficiently served by large catalog distributors with centralized warehouses.